163 related articles for article (PubMed ID: 2108856)
21. Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase.
Gong M; He X; Song J; Zhao B; Shi W; Chen G; Gu J
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1333-1339. PubMed ID: 29768935
[TBL] [Abstract][Full Text] [Related]
22. Thrombolysis for pulmonary embolism.
Böttiger BW; Böhrer H
Lancet; 1992 Oct; 340(8823):852. PubMed ID: 1357272
[No Abstract] [Full Text] [Related]
23. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
Goldhaber SZ; Kessler CM; Heit J; Markis J; Sharma GV; Dawley D; Nagel JS; Meyerovitz M; Kim D; Vaughan DE
Lancet; 1988 Aug; 2(8606):293-8. PubMed ID: 2899718
[TBL] [Abstract][Full Text] [Related]
24. Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapy.
Volgesang GB; Bell WR
Clin Chest Med; 1984 Sep; 5(3):487-94. PubMed ID: 6386293
[TBL] [Abstract][Full Text] [Related]
25. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
Dalen JE; Alpert JS; Hirsh J
Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
[No Abstract] [Full Text] [Related]
26. [Intraoperative thrombolysis with rt-PA in massive pulmonary embolism during venous thrombectomy].
Scheeren TW; Hopf HB; Peters J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Nov; 29(7):440-5. PubMed ID: 7819477
[TBL] [Abstract][Full Text] [Related]
27. [Cost-benefit study of different thrombolytic strategies in treating 156 patients with symptomatic pulmonary thromboembolism].
Li XS; Deng XY; Liu HL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jun; 24(6):355-6. PubMed ID: 22681664
[TBL] [Abstract][Full Text] [Related]
28. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
Theiss W
Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
[No Abstract] [Full Text] [Related]
29. [Chronic effects of 100 mg/2 hours recombinant tissue-type plasminogen activator therapy regimen for patients with acute pulmonary thromboembolism].
Li ZP; Xu B; Jiang R; Li JL; Jiang X; Sun ML; Jing ZC; Li YP
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):224-8. PubMed ID: 23879948
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
[TBL] [Abstract][Full Text] [Related]
31. Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.
Levine MN
Chest; 1991 Apr; 99(4 Suppl):128S-134S. PubMed ID: 2009809
[TBL] [Abstract][Full Text] [Related]
32. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.
Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C
Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030
[TBL] [Abstract][Full Text] [Related]
33. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
[TBL] [Abstract][Full Text] [Related]
34. Evolving concepts in thrombolytic therapy for pulmonary embolism.
Goldhaber SZ
Chest; 1992 Apr; 101(4 Suppl):183S-185S. PubMed ID: 1555483
[TBL] [Abstract][Full Text] [Related]
35. Studies on the medical treatment of deep vein thrombosis.
Schulman S
Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
[TBL] [Abstract][Full Text] [Related]
36. Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis.
Tarry WC; Makhoul RG; Tisnado J; Posner MP; Sobel M; Lee HM
Ann Vasc Surg; 1994 Nov; 8(6):583-90. PubMed ID: 7865398
[TBL] [Abstract][Full Text] [Related]
37. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Turpie AG; Levine MN; Hirsh J; Ginsberg JS; Cruickshank M; Jay R; Gent M
Chest; 1990 Apr; 97(4 Suppl):172S-175S. PubMed ID: 2108855
[TBL] [Abstract][Full Text] [Related]
38. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.
Schweizer J; Elix H; Altmann E; Hellner G; Forkmann L
Vasa; 1998 Aug; 27(3):167-71. PubMed ID: 9747153
[TBL] [Abstract][Full Text] [Related]
39. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
[TBL] [Abstract][Full Text] [Related]
40. Thrombolytic therapy in pulmonary embolism of Behçet's disease.
Sanchez-Burson J; Corzo JE; Marenco JL; Rejon-Gieb E
Acta Haematol; 1996; 96(3):181-3. PubMed ID: 8876617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
